Pacifica Capital Investments LLC acquired a new stake in shares of Rentokil Initial plc (NYSE:RTO – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 193,305 shares of the company’s stock, valued at approximately $4,894,000. Rentokil Initial accounts for 1.6% of Pacifica Capital Investments LLC’s portfolio, making the stock its 9th biggest holding.
A number of other large investors also recently bought and sold shares of the business. River Road Asset Management LLC lifted its holdings in shares of Rentokil Initial by 114.2% in the 4th quarter. River Road Asset Management LLC now owns 3,786,010 shares of the company’s stock worth $95,862,000 after buying an additional 2,018,866 shares during the period. Janus Henderson Group PLC lifted its holdings in shares of Rentokil Initial by 3.8% in the 3rd quarter. Janus Henderson Group PLC now owns 16,990,179 shares of the company’s stock worth $423,573,000 after buying an additional 617,227 shares during the period. Maverick Capital Ltd. purchased a new stake in shares of Rentokil Initial in the 3rd quarter worth $14,820,000. Harvey Partners LLC lifted its holdings in shares of Rentokil Initial by 48.3% in the 3rd quarter. Harvey Partners LLC now owns 1,430,000 shares of the company’s stock worth $35,650,000 after buying an additional 465,500 shares during the period. Finally, Raymond James Financial Inc. purchased a new stake in shares of Rentokil Initial in the 4th quarter worth $11,436,000. Hedge funds and other institutional investors own 9.91% of the company’s stock.
Wall Street Analyst Weigh In
Several equities research analysts have weighed in on RTO shares. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Rentokil Initial in a report on Friday, March 7th. Citigroup upgraded Rentokil Initial to a “strong-buy” rating in a research note on Friday, December 13th. Four analysts have rated the stock with a hold rating, one has assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy”.
Rentokil Initial Trading Down 0.1 %
Shares of NYSE RTO opened at $22.50 on Monday. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.04 and a quick ratio of 0.96. The stock has a market capitalization of $11.36 billion, a P/E ratio of 14.90, a price-to-earnings-growth ratio of 7.95 and a beta of 1.14. Rentokil Initial plc has a 1-year low of $20.60 and a 1-year high of $34.07. The business has a fifty day moving average price of $24.29 and a 200 day moving average price of $25.06.
Rentokil Initial Dividend Announcement
The firm also recently announced a semi-annual dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 4th will be given a dividend of $0.3825 per share. This represents a yield of 2.4%. The ex-dividend date is Friday, April 4th. Rentokil Initial’s dividend payout ratio is currently 43.71%.
About Rentokil Initial
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
Read More
- Five stocks we like better than Rentokil Initial
- What is the Euro STOXX 50 Index?
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 3 ETFs to Ride the VIX Surge During Market Volatility
- Options Trading – Understanding Strike Price
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Want to see what other hedge funds are holding RTO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rentokil Initial plc (NYSE:RTO – Free Report).
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.